- $5.23bn
- $5.42bn
- $4.09bn
- 54
- 60
- 99
- 83
Annual income statement for PACS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1,167 | 2,422 | 3,111 | 4,090 |
| Cost of Revenue | ||||
| Gross Profit | 265 | 561 | 664 | 793 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 1,083 | 2,193 | 2,904 | 3,959 |
| Operating Profit | 83.4 | 229 | 208 | 131 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 81.4 | 207 | 157 | 102 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 47.9 | 150 | 113 | 55.3 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 47.9 | 150 | 113 | 55.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 47.9 | 150 | 113 | 55.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.324 | 1.02 | 0.764 | 0.278 |